You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 29, 2024

CLINICAL TRIALS PROFILE FOR DANOCRINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for Danocrine

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01667263 ↗ The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia Completed Beijing Hospital Phase 2 2012-06-01 Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.
NCT01667263 ↗ The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia Completed Beijing Municipal Science & Technology Commission Phase 2 2012-06-01 Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.
NCT01667263 ↗ The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia Completed Beijing Tongren Hospital Phase 2 2012-06-01 Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.
NCT01667263 ↗ The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia Completed Navy General Hospital, Beijing Phase 2 2012-06-01 Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.
NCT01667263 ↗ The Combination of ATRA and Danazol as Second-line Treatment in Adult Immune Thrombocytopenia Completed Qilu Hospital of Shandong University Phase 2 2012-06-01 Randomized, open-label, multicentre study to compare the efficacy and safety of ATRA plus danazol with danazol monotherapy in patients with corticosteroid-resistant/relapsed ITP.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Danocrine

Condition Name

Condition Name for Danocrine
Intervention Trials
Immune Thrombocytopenia 3
Primary Myelofibrosis 2
Physiological Effects of Drugs 1
Post-essential Thrombocythemia Myelofibrosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Danocrine
Intervention Trials
Thrombocytopenia 4
Purpura, Thrombocytopenic, Idiopathic 4
Primary Myelofibrosis 2
Polycythemia Vera 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Danocrine

Trials by Country

Trials by Country for Danocrine
Location Trials
United States 14
France 11
Poland 9
Hungary 8
Italy 8
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Danocrine
Location Trials
New York 2
Arizona 2
Texas 1
Pennsylvania 1
Ohio 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Danocrine

Clinical Trial Phase

Clinical Trial Phase for Danocrine
Clinical Trial Phase Trials
Phase 3 1
Phase 2 4
Phase 1/Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Danocrine
Clinical Trial Phase Trials
Recruiting 2
Completed 2
Not yet recruiting 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Danocrine

Sponsor Name

Sponsor Name for Danocrine
Sponsor Trials
Peking University People's Hospital 4
Beijing Municipal Science & Technology Commission 1
Beijing Tongren Hospital 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Danocrine
Sponsor Trials
Other 10
Industry 1
NIH 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.